7-hydroxymitragynine (7-OH)

-hydroxymitragynine (7-OH) is a potent, opioid-like chemical found in the Southeast Asian kratom plant (Mitragyna speciosa). While it occurs naturally in small amounts in the plant, concentrated versions of 7-OH have emerged as a significant public health

Moderators

BENJAMIN ZOHAR

Intervention New York

Discussions Archivos Imágenes Videos Enlaces Eventos Knowledge Share Todo(s)

Long Island drug rehabs—common insurance accepted (Aetna, Empire BCBS, Cigna, UnitedHealthcare, EmblemHealth, Fidelis Care, Healthfirst, Medicare, Medicaid).

Explore Long Island drug rehab programs—Residential, PHP, IOP—plus professional interventions, an outpatient option in Baldwin (Integrity Treatment Partners), and county detox resource links. Includes a keyword-first Google Maps (CID) link for directions and internal links to Residential, PHP, Alcohol/Drug pages, Interventions, and Our Location.

Clinical education banner showing a healthcare professional reviewing kratom and 7-hydroxymitragynine (7-OH) data in a detox treatment setting, with text reading “7-Hydroxymitragynine (7-OH): Clinical Insights and Buprenorphine-Based Management.”

Educational overview on kratom’s potent alkaloid 7-hydroxymitragynine (7-OH) and its opioid-like withdrawal potential. Highlights the rise of kratom dependence cases across New York, clinical findings from peer-reviewed literature, and emerging success of buprenorphine-based treatment protocols. Includes key facts, U.S. regulatory context, and resource links from NIDA, SAMHSA, and FDA to support safe detox and recovery practices.

Kratom addiction in Long Island – 7-OH detox awareness banner.

Educational overview of kratom addiction and severe withdrawal emerging in Long Island and New York, detailing 7-OH risks, FDA and local laws, and safe pathways to treatment.

Visual graphic with New York context, warning icon, and pills representing kratom’s risks, alongside community solutions like free drug tests and intervention services

In recent years, the rise of 7-hydroxymitragynine (7-OH) — one of the most potent alkaloids found in kratom — has raised serious concerns across New York State. While kratom is often marketed as a “natural” supplement, research shows that 7-OH has powerful opioid-like effects, leading to dependence, withdrawal, and even overdose when misused.

Why Accessibility Is a Public Health Issue

New York lawmakers are beginning to respond to this growing threat. In 2025, Senate Bill S7379 was introduced, proposing to add kratom to the list of Schedule I controlled substances under state law...

The U.S. Food and Drug Administration today is taking a bold step to protect Americans from dangerous, illegal opioids by recommending a scheduling action to control certain 7-hydroxymitragynine (also known as 7-OH) products under the Controlled Substances Act (CSA). The FDA is specifically...

Dangers of 7OH

Upcoming Events

There aren't any upcoming events

All Events

7-hydroxymitragynine (7-OH)

Drug Rehab Programs on Long Island: Interventions, PHP/IOP & Resources

7-Hydroxymitragynine (7-OH) and Kratom Withdrawal: Clinical Insights and Buprenorphine-Based Management

Kratom Addiction in Long Island: Understanding 7-Hydroxymitragynine (7-OH) and the Rise of Severe Withdrawal Cases

The Dangers of 7-OH and Why Accessibility in New York Matters

FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers

Upcoming Events